Dr. Anum Shahzad, MD

Dr. Shahzad practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Shahzad's NPI, 1285163576, was assigned on June 8, 2017. Dr. Shahzad holds Colorado license DR.0070732.

Dr. Shahzad's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Shahzad's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Shahzad is also affiliated with UCHealth Poudre Valley Hospital. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Shahzad to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shahzad practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Shahzad's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Shahzad's licenses on file in 2 states: Colorado and Pennsylvania.

CMS data shows 83 Medicare services from Dr. Shahzad across 2 procedure codes in 2024, for 95 Medicare patients. Medicare paid $4,864 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Shahzad in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 17% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shahzad's median patient age at 69, with 49% women.

In 2024, Dr. Shahzad wrote 181 Medicare Part D claims for 26 patients. 78% of them were for generic drugs. CMS names the drug for 97 of them, across 6 drugs with 11 or more claims each, at $725 in total drug cost. In 2022, CMS named 158 claims across 9 drugs.

Dr. Shahzad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Shahzad, published from 2020 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists and Electrocardiography. Dr. Shahzad's most frequent co-authors are Janani Rangaswami, MD, Peter Andrew McCullough, MD, MPH and Jerald Lalaguna Pelayo, MD.

CMS Open Payments shows 51 general payments to Dr. Shahzad from 16 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 82% of the total. Biotronik Inc. paid the most, $365.